Advertisement
Outsourcing
Subscribe to Outsourcing

The Lead

Metrics Contract Service Reveals New Name and Logo

August 8, 2014 8:44 am | News | Comments

Metrics Contract Services, a full-service contract pharmaceutical formulation development and manufacturing organization, has adopted a new and more descriptive name.              

PCI Announces Definitive Agreement to Acquire Penn Pharma

July 30, 2014 8:38 am | News | Comments

Packaging Coordinators has reached a definitive agreement to acquire Penn Pharmaceutical...

Novogen and CanTx Appoint Contract Manufacturers to Produce Clinical Batches of Cantrixil

July 25, 2014 8:16 am | News | Comments

Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that...

Aptuit Names Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities

July 16, 2014 11:33 am | News | Comments

Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business...

View Sample

FREE Email Newsletter

Chiltern Acquires Ockham - Companies Merge Operations

July 15, 2014 11:45 am | News | Comments

Chiltern and Ockham, two full-service contract research organizations (CROs), today announce that Chiltern has acquired 100% of Ockham and that the companies will merge their operations. The combined company will be called Chiltern. Ockham's management team will join the management of the enlarged group, thus ensuring a seamless continuation of high quality services.

Getting Very Personal: The PCT Story

July 8, 2014 2:35 pm | by Mike Auerbach, Editor In Chief | Articles | Comments

Mention the terms ‘cell therapy’ or ‘regenerative medicine’ and many in the general public are still confused as to what those terms actually mean. But those in the know understand that cell therapy is a growing and thriving industry, with great potential to change the face of modern healthcare.

AAIPharma Services and Cambridge Major Laboratories Name New CEO

July 8, 2014 8:54 am | News | Comments

AAIPharma Services Corp., a global provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, Inc., a provider pharmaceutical API development and manufacturingservices, announced the appointment of Stephan Kutzer, Ph.D. as Chief Executive Officer (CEO), effective August 1, 2014.

Advertisement

Metrics Expands Drug Delivery Options with Spray Dryer Acquisition

June 27, 2014 9:01 am | News | Comments

Metrics Inc. has expanded its already robust options for enhancing drug bioavailability thanks to the recent acquisition of a BÜCHI B-290 Mini Spray Dryer. The dryer’s core capability is rendering powder from a solution, said Brad Gold, Ph.D., vice president of pharmaceutical development.

BASi Names Names New CFO and VP Bioanalytical Operations

June 12, 2014 8:27 am | News | Comments

Bioanalytical Systems, Inc. (BASi) today announced the appointment of Jeffrey Potrzebowski as Chief Financial Officer and James S. Bourdage, Ph.D., as Vice President Bioanalytical Operations.          

Xcelience Opens UK/European Packaging and Distribution Hub

June 10, 2014 11:24 am | News | Comments

Xcelience announced today the opening of a 3,000 square foot facility in Birmingham, UK, making it the first small to mid-sized American CDMO to launch international operations. The new plant will become a gateway for the Florida-based company’s clinical packaging and distribution services in the UK, Europe and abroad.

Frontage Labs Plans Expansion of CMC Facility

June 3, 2014 9:51 am | News | Comments

Frontage Labs today announced plans to expand its chemistry, manufacturing and controls (CMC) facility in Exton, P.A. The expansion includes significant incremental capacity to existing services, and will also provide Frontage with additional room for future growth.

Bristol-Myers Squibb and Syngene International Extend Research Collaboration

June 3, 2014 8:18 am | News | Comments

Bristol-Myers Squibb and Syngene International, India’s largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration in India.         

Advertisement

AMRI to Acquire Oso Biopharmaceuticals Manufacturing

June 2, 2014 9:01 am | News | Comments

AMRI has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, for $110M in cash. OsoBio is a contract manufacturer of highly complex injectable drug products, including sterile liquid, suspension and lyophilized formulations.

WuXi PharmaTech Begins Operation of New High-Potency API Laboratory

May 28, 2014 8:13 am | News | Comments

WuXi PharmaTech today announced that its manufacturing subsidiary, Syn-The-All Pharmaceutical Co., Ltd. (STA), has begun operation of a high-potency active pharmaceutical ingredient (HPAPI) laboratory in Shanghai, thereby adding HPAPI processing to its portfolio of services.

PAREXEL Names Chief Scientific Officer

May 27, 2014 9:07 am | News | Comments

PAREXEL International, a global biopharmaceutical services organization, today named Dr. Sy Pretorius its Chief Scientific Officer. Dr. Pretorius currently serves as the company's Corporate Vice President and Worldwide Head of Early Phase, and will continue in that capacity in addition to assuming his expanded responsibilities.

Relypsa Announces Commercial Manufacturing Agreement With DSM Fine Chemicals

May 20, 2014 9:07 am | News | Comments

Relypsa, a biopharmaceutical company, today announced that it has entered into a multi-year commercial manufacturing and supply agreement with DSM Fine Chemicals Austria NFG GMBH & Co. KG for the active pharmaceutical ingredient for patiromer, the company's novel polymer in development for the treatment of hyperkalemia.

Lannett Announces Multi-Services Agreement with Sunshine Lake LLC

May 12, 2014 7:57 am | News | Comments

Lannett Company announced that it has entered into distribution and contract manufacturing services agreements with Sunshine Lake LLC, the U.S. subsidiary of the HEC Pharm Group (HEC) of Shenzhen, Guangdong Province, China.     

Advertisement

Pharmaceutical Processing's May 2014 Edition

May 9, 2014 12:00 am | Digital Editions | Comments

The May issue of Pharmaceutical Processing profiles PCI, a contract developer and manufacturer of custom NCEs, fine chemicals and generic APIs based in Newburyport, MA. We also take a look at the critical success factors clients evaluate when choosing a CMO. Our manufacturing services Q&A discusses current trends, issues and the future of pharmaceutical processing services. In addition we cover tablet coating, single-use technologies and QbD in test method development and validation.

Boston Therapeutics Signs Agreement With Patheon to Manufacture Pharmaceutical-Grade BTI-320 Tablets

May 6, 2014 8:02 am | News | Comments

Boston Therapeutics and its Hong Kong-based strategic partner Advance Pharmaceutical Company, have signed an agreement with Patheon to manufacture pharmaceutical-grade tablets of the company's lead product candidate BTI-320, a compound designed to reduce post-meal elevation of blood glucose.

CMOs Most Critical to Success Factors

April 30, 2014 8:38 am | by Eric Langer, President and Managing Partner, BioPlan Associates | Articles | Comments

Outsourcing continues to be an integral part of biopharmaceutical manufacturing, and facilities are outsourcing activities today at heightened levels. As a result, the contract manufacturing organization (CMO) community has seen an expansion of opportunities, leading to increased competition.  In this science and technology-driven environment, how can CMOs separate themselves from the pack?

Quintiles and Biogen Idec Announce Clinical Development Partnership

April 24, 2014 8:08 am | News | Comments

Quintiles, a provider of biopharmaceutical development and commercial outsourcing services, and Biogen Idec  have entered into a five-year strategic clinical development agreement. The multi-year collaboration is designed to leverage the expertise and experience from both organizations to optimize Biogen Idec’s clinical development processes.

Entrepreneurial Spirit

April 22, 2014 3:19 pm | by Mike Auerbach, Editor in Chief | Articles | Comments

PCI, Inc. a contract manufacturing and research organization based in Newburyport, MA that develops and manufactures NCEs, generic APIs and fine chemicals has grown from a small start-up to a company that can now take a product all the way from development to commercial production in a smooth and seamless process for its clients.

AMRI Closing Syracuse-Area Lab in July

April 17, 2014 11:33 am | News | Comments

Albany Molecular Research Inc. announced Wednesday that it will close its 12-year-old facility in Cicero on July 15. Some employees will be transferred to Albany, Cedarburg, Wis., England and India.         

Pharmaceutical Processing's April 2014 Edition

April 11, 2014 12:00 am | Digital Editions | Comments

The April issue of Pharmaceutical Processing profiles Reed-Lane, a contract packager of solid-dosage products based in Wayne, NJ. Additional articles on contract services and outsourcing topics include a look at the global biosimilars market and an update on solid dosage manufacturing services. In addition, the benefits of using ready-to-fill vials is explored. Other topics covered in this issue include packaging inspection, anti-counterfeiting technologies, lab design and expediting drug development.

UPM to Manufacture Generic Commercial Products for Amerigen Pharmaceuticals

April 2, 2014 1:44 pm | News | Comments

UPM, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with Amerigen Pharmaceuticals, Inc. to commercially manufacture two ANDA products for a 10 year supply term.          

High-Potency Product Manufacturing - Key Selection Criteria When Evaluating an Outsourcing Partner

March 27, 2014 11:32 am | White Papers

Approximately 25% of drugs in development worldwide are classified as highly potent, with this percentage expected to grow over the coming years. While such highly potent compounds can have significant benefits in the treatment of certain medical conditions, they present substantial challenges to the pharmaceutical industry.

Flexible Packaging - Growth and Flexibility Make Reed-Lane a Valuable Packaging Partner

March 27, 2014 9:07 am | by Mike Auerbach, Editor-in Chief | Articles | Comments

No two packaging projects are alike and in order to make it all work and to keep everything on track and everyone happy you need to have a flexible, responsive and quality-driven organizations. Reed-Lane has deftly combined these qualities along with recent investments to create a truly flexible contract packaging operation.

Catalent Increases Stake in Redwood Bioscience

March 24, 2014 10:48 am | News | Comments

Catalent Pharma Solutions today announced that based on compelling data generated by the SMARTag™ ADC platform, it has increased its minority investment in Redwood Bioscience.             

AMRI to Acquire Cedarburg Pharmaceuticals

March 24, 2014 7:58 am | News | Comments

AMRI has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals, Inc. for $38.2 million in cash. The transaction, including $2.8 million of assumed liabilities, is valued at $41 million.     

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading